CAP1 and central nervous system cancer: For instance, CAP1 has been shown to be overexpressed in pancreatic cancer [15], esophageal squamous cell carcinoma [16], lung cancer [17], hepatocellular carcinoma [18], epithelial ovarian cancer [19], breast cancer [20], and glioma [21,22].